CN107913383A - 一种治疗急性胃粘膜病变的中西复方药物及制备方法 - Google Patents
一种治疗急性胃粘膜病变的中西复方药物及制备方法 Download PDFInfo
- Publication number
- CN107913383A CN107913383A CN201710029295.9A CN201710029295A CN107913383A CN 107913383 A CN107913383 A CN 107913383A CN 201710029295 A CN201710029295 A CN 201710029295A CN 107913383 A CN107913383 A CN 107913383A
- Authority
- CN
- China
- Prior art keywords
- parts
- medicine
- western
- chinese
- root
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000003814 drug Substances 0.000 title claims abstract description 107
- 206010061164 Gastric mucosal lesion Diseases 0.000 title claims abstract description 27
- 150000001875 compounds Chemical class 0.000 title claims abstract description 19
- 238000002360 preparation method Methods 0.000 title claims abstract description 7
- 239000002994 raw material Substances 0.000 claims abstract description 22
- 240000000588 Hericium erinaceus Species 0.000 claims abstract description 19
- 235000007328 Hericium erinaceus Nutrition 0.000 claims abstract description 19
- 244000081923 Rumex patientia Species 0.000 claims abstract description 18
- 235000008330 Rumex patientia Nutrition 0.000 claims abstract description 18
- 241000219357 Cactaceae Species 0.000 claims abstract description 17
- 241000208308 Coriandrum Species 0.000 claims abstract description 17
- 241000735527 Eupatorium Species 0.000 claims abstract description 17
- 240000002853 Nelumbo nucifera Species 0.000 claims abstract description 17
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims abstract description 17
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims abstract description 17
- 229940079593 drug Drugs 0.000 claims abstract description 17
- 241001116415 Balanophora Species 0.000 claims abstract description 16
- 240000003690 Callicarpa japonica Species 0.000 claims abstract description 16
- 235000017595 Callicarpa japonica Nutrition 0.000 claims abstract description 16
- 241000219071 Malvaceae Species 0.000 claims abstract description 16
- 235000003283 Pachira macrocarpa Nutrition 0.000 claims abstract description 16
- 244000175269 Smilax herbacea Species 0.000 claims abstract description 16
- 235000014364 Trapa natans Nutrition 0.000 claims abstract description 16
- CCGSUNCLSOWKJO-UHFFFAOYSA-N cimetidine Chemical compound N#CNC(=N/C)\NCCSCC1=NC=N[C]1C CCGSUNCLSOWKJO-UHFFFAOYSA-N 0.000 claims abstract description 16
- 229960001380 cimetidine Drugs 0.000 claims abstract description 16
- 239000001814 pectin Substances 0.000 claims abstract description 16
- 235000010987 pectin Nutrition 0.000 claims abstract description 16
- 229920001277 pectin Polymers 0.000 claims abstract description 16
- 235000009165 saligot Nutrition 0.000 claims abstract description 16
- KZFDVWZZYOPBQZ-UHFFFAOYSA-K bismuth;potassium;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [K+].[Bi+3].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KZFDVWZZYOPBQZ-UHFFFAOYSA-K 0.000 claims abstract description 15
- 239000004615 ingredient Substances 0.000 claims abstract description 10
- 238000000034 method Methods 0.000 claims abstract description 4
- 239000000203 mixture Substances 0.000 claims description 36
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 19
- 239000000843 powder Substances 0.000 claims description 16
- 241001083492 Trapa Species 0.000 claims description 15
- 238000001914 filtration Methods 0.000 claims description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 12
- 235000006886 Zingiber officinale Nutrition 0.000 claims description 12
- 239000000706 filtrate Substances 0.000 claims description 12
- 235000008397 ginger Nutrition 0.000 claims description 12
- 239000012153 distilled water Substances 0.000 claims description 9
- 239000004570 mortar (masonry) Substances 0.000 claims description 9
- 230000001154 acute effect Effects 0.000 claims description 6
- 210000001156 gastric mucosa Anatomy 0.000 claims description 6
- 239000012535 impurity Substances 0.000 claims description 6
- 230000003902 lesion Effects 0.000 claims description 6
- 238000010992 reflux Methods 0.000 claims description 6
- 230000008859 change Effects 0.000 claims description 4
- 238000009835 boiling Methods 0.000 claims description 3
- 238000007654 immersion Methods 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 230000005855 radiation Effects 0.000 claims description 3
- 230000001954 sterilising effect Effects 0.000 claims description 3
- 238000004659 sterilization and disinfection Methods 0.000 claims description 3
- 229910052797 bismuth Inorganic materials 0.000 claims description 2
- JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 claims description 2
- 244000273928 Zingiber officinale Species 0.000 claims 4
- 244000025254 Cannabis sativa Species 0.000 claims 1
- 241000282994 Cervidae Species 0.000 claims 1
- 235000002710 Ilex cornuta Nutrition 0.000 claims 1
- 241001310146 Ilex cornuta Species 0.000 claims 1
- 235000010326 Osmanthus heterophyllus Nutrition 0.000 claims 1
- YPQJHZKJHIBJAP-UHFFFAOYSA-N [K].[Bi] Chemical compound [K].[Bi] YPQJHZKJHIBJAP-UHFFFAOYSA-N 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 239000000084 colloidal system Substances 0.000 claims 1
- 208000024891 symptom Diseases 0.000 abstract description 15
- 239000008280 blood Substances 0.000 abstract description 14
- 210000004369 blood Anatomy 0.000 abstract description 14
- 230000000694 effects Effects 0.000 abstract description 11
- 208000032843 Hemorrhage Diseases 0.000 abstract description 9
- 206010046274 Upper gastrointestinal haemorrhage Diseases 0.000 abstract description 8
- 206010047700 Vomiting Diseases 0.000 abstract description 8
- 230000000740 bleeding effect Effects 0.000 abstract description 8
- 235000013305 food Nutrition 0.000 abstract description 7
- 208000001118 melena Diseases 0.000 abstract description 7
- 230000001737 promoting effect Effects 0.000 abstract description 7
- 210000000952 spleen Anatomy 0.000 abstract description 7
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 abstract description 6
- 230000029087 digestion Effects 0.000 abstract description 6
- 230000001225 therapeutic effect Effects 0.000 abstract description 6
- 206010053155 Epigastric discomfort Diseases 0.000 abstract description 5
- 230000009471 action Effects 0.000 abstract description 4
- 230000000202 analgesic effect Effects 0.000 abstract description 4
- 230000036528 appetite Effects 0.000 abstract description 4
- 235000019789 appetite Nutrition 0.000 abstract description 4
- 230000004087 circulation Effects 0.000 abstract description 4
- 210000004051 gastric juice Anatomy 0.000 abstract description 4
- 230000004936 stimulating effect Effects 0.000 abstract description 4
- 230000008673 vomiting Effects 0.000 abstract description 4
- 102000004190 Enzymes Human genes 0.000 abstract description 3
- 108090000790 Enzymes Proteins 0.000 abstract description 3
- 229940000425 combination drug Drugs 0.000 abstract description 3
- 230000000295 complement effect Effects 0.000 abstract description 3
- 230000007797 corrosion Effects 0.000 abstract description 3
- 238000005260 corrosion Methods 0.000 abstract description 3
- 238000005516 engineering process Methods 0.000 abstract description 3
- 230000000977 initiatory effect Effects 0.000 abstract description 3
- 230000007721 medicinal effect Effects 0.000 abstract description 3
- 210000004877 mucosa Anatomy 0.000 abstract description 2
- 240000001085 Trapa natans Species 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 12
- 230000010412 perfusion Effects 0.000 description 12
- 201000010099 disease Diseases 0.000 description 11
- 238000011084 recovery Methods 0.000 description 9
- 241000234314 Zingiber Species 0.000 description 8
- 239000000243 solution Substances 0.000 description 7
- 230000006870 function Effects 0.000 description 6
- 230000023597 hemostasis Effects 0.000 description 6
- 208000007882 Gastritis Diseases 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 238000012545 processing Methods 0.000 description 4
- 206010007247 Carbuncle Diseases 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 206010019233 Headaches Diseases 0.000 description 3
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- 206010067171 Regurgitation Diseases 0.000 description 3
- 208000025865 Ulcer Diseases 0.000 description 3
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 3
- 238000011047 acute toxicity test Methods 0.000 description 3
- 208000001848 dysentery Diseases 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 241000411851 herbal medicine Species 0.000 description 3
- 235000012054 meals Nutrition 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 206010036067 polydipsia Diseases 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 208000017667 Chronic Disease Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- 206010020565 Hyperaemia Diseases 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 208000004078 Snake Bites Diseases 0.000 description 2
- 208000019790 abdominal distention Diseases 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 208000026935 allergic disease Diseases 0.000 description 2
- 230000007815 allergy Effects 0.000 description 2
- 208000034158 bleeding Diseases 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 208000021735 chronic enteritis Diseases 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 208000000718 duodenal ulcer Diseases 0.000 description 2
- 208000001780 epistaxis Diseases 0.000 description 2
- 230000003628 erosive effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000003304 gavage Methods 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- 201000001881 impotence Diseases 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 231100001252 long-term toxicity Toxicity 0.000 description 2
- 230000036407 pain Effects 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 206010037844 rash Diseases 0.000 description 2
- 201000010727 rectal prolapse Diseases 0.000 description 2
- 230000029058 respiratory gaseous exchange Effects 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 230000008736 traumatic injury Effects 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 208000010470 Ageusia Diseases 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 241001106067 Atropa Species 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- 208000017897 Carcinoma of esophagus Diseases 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 208000000461 Esophageal Neoplasms Diseases 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 206010017865 Gastritis erosive Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 208000032139 Halitosis Diseases 0.000 description 1
- 208000032456 Hemorrhagic Shock Diseases 0.000 description 1
- 206010021531 Impetigo Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000005016 Intestinal Neoplasms Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 206010061297 Mucosal erosion Diseases 0.000 description 1
- 206010061298 Mucosal haemorrhage Diseases 0.000 description 1
- 208000005647 Mumps Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 235000003143 Panax notoginseng Nutrition 0.000 description 1
- 241000180649 Panax notoginseng Species 0.000 description 1
- 240000005373 Panax quinquefolius Species 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 241000219000 Populus Species 0.000 description 1
- 206010037549 Purpura Diseases 0.000 description 1
- 241001672981 Purpura Species 0.000 description 1
- YDBYJHTYSHBBAU-YFKPBYRVSA-N S-methyl-L-methioninate Chemical compound C[S+](C)CC[C@H](N)C([O-])=O YDBYJHTYSHBBAU-YFKPBYRVSA-N 0.000 description 1
- 206010049771 Shock haemorrhagic Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 206010042220 Stress ulcer Diseases 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- YSIITVVESCNIPR-UHFFFAOYSA-N Troxipide Chemical compound COC1=C(OC)C(OC)=CC(C(=O)NC2CNCCC2)=C1 YSIITVVESCNIPR-UHFFFAOYSA-N 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000002605 anti-dotal effect Effects 0.000 description 1
- 229940030225 antihemorrhagics Drugs 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 229940030606 diuretics Drugs 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 210000001198 duodenum Anatomy 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 150000002301 glucosamine derivatives Chemical class 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000000025 haemostatic effect Effects 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 230000002008 hemorrhagic effect Effects 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 201000002313 intestinal cancer Diseases 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 201000005630 leukorrhea Diseases 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 201000002266 mite infestation Diseases 0.000 description 1
- 208000010805 mumps infectious disease Diseases 0.000 description 1
- 230000001114 myogenic effect Effects 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 229960002748 norepinephrine Drugs 0.000 description 1
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000004224 protection Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 206010043554 thrombocytopenia Diseases 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 229960001341 troxipide Drugs 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 206010046901 vaginal discharge Diseases 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/732—Pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/33—Cactaceae (Cactus family), e.g. pricklypear or Cereus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/62—Nymphaeaceae (Water-lily family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/85—Verbenaceae (Verbena family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/89—Cyperaceae (Sedge family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9062—Alpinia, e.g. red ginger or galangal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种治疗急性胃粘膜病变的中西复方药物及制备方法,属医药技术领域;本发明药物成分的原料组成为:猴头菇,荷叶,鹿仙草,牛西西,胡荽,佩兰,仙人掌,南姜,荸荠,木棉根,栘枍,紫珠,花荵,胶体果胶铋,西咪替丁和枸橼酸铋钾;本发明药物采用中西医药结合的治疗方法比一般单纯的用中药、西药的治疗效果更佳,以收敛止血、消食开胃、止痛止呕、行气消食、健脾开胃为治疗原则,可以最大效率的提高中药成分与西药功效,发挥互补和提升作用,提高药用效果,且能够隔绝胃酸、酶及食物对溃疡粘膜的侵蚀作用,对急性胃粘膜病变引发的上消化道出血、呕血、黑粪、上腹部不适等症状具有良好的治疗效果。
Description
所属技术领域
本发明涉及医药技术领域,尤其涉及一种治疗急性胃粘膜病变的中西复方药物及制备方法。
背景技术
急性胃粘膜病变是以胃粘膜发生不同程度糜烂、浅溃疡和出血为特征的病变,以急性粘膜糜烂病变为主者称急性糜烂性胃炎,以粘膜出血改变为主可称为急性出血性胃炎,发生于应激状态,以多发性溃疡为主者可称为应激性溃疡。口服胃粘膜屏障破坏剂为导致急性胃粘膜病变的首要原因,常表现为上消化道出血。
上消化道出血是急性胃粘膜病变最突出的症状,可表现为呕血或黑粪,其特点是:①有服用有关药物、酗酒或可导致应激状态的疾病史。②起病骤然,突然呕血、黑粪。可出现在应激性病变之后数小时或数日。③出血量多,可呈间歇性、反复多次,常导致出血性休克。起病时也可伴上腹部不适,烧灼感、疼痛、恶心、呕吐及反酸等症状。
急性胃粘膜病变虽然病因各异,但发病机制、病理、临床表现、治疗均相似,故一并讨论。本病是上消化道出血的常见病因之一,约占20~30%,应及时对患者止血,并补充溶血量。目前所使用的止血药物有白药、三七粉或经胃管吸出酸性胃液,用去甲肾上腺素8mg加入100ml冷盐水中,用5%葡萄糖盐水静脉输入补充血糖等,但见效稍慢,且易反复发作。因此,结合中医疗法和西医疗法,研究出一种疗效确切见效又快的治疗急性胃粘膜病变的中西复方药物是很有价值的。
发明内容
本发明提供了一种治疗急性胃粘膜病变的中西复方药物及制备方法,本发明
药物采用中西医药结合的治疗方法比一般单纯的用中药、西药的治疗效果更佳,以收敛止血、消食开胃、止痛止呕、行气消食、健脾开胃为治疗原则,可以最大效率的提高中药成分与西药功效,发挥互补和提升作用,提高药用效果,且能够隔绝胃酸、酶及食物对溃疡粘膜的侵蚀作用应,对急性胃粘膜病变引发的上消化道出血、呕血、黑粪、上腹部不适等症状具有良好的治疗效果;本发明药物针对性强,服用方便,吸收效果好,疗效显著,经临床验证,疗程短、治愈率高、标本兼治、成本低,是一种值得大量推广应用的药物。
为实现上述目的,本发明的技术方案实施如下:
一种治疗急性胃粘膜病变的中西复方药物,所述药物由中药和西药成分组成,制成所述中药成分的原料组成及重量份数为:猴头菇54~84份,荷叶51~81份,鹿仙草49~79份,牛西西47~77份,胡荽44~74份,佩兰39~69份,仙人掌36~66份,南姜34~64份,荸荠32~62份,木棉根29~59份,栘枍27~57份,紫珠25~55份,花荵24~54份;制成所述西药成分的原料组成及重量份数为:胶体果胶铋0.4~1.8份,西咪替丁0.3~1.7份,枸橼酸铋钾0.2~1.6份。
所述药物由中药和西药成分组成,制成所述中药成分的原料组成及重量份数为:猴头菇77份,荷叶74份,鹿仙草72份,牛西西70份,胡荽67份,佩兰62份,仙人掌60份,南姜58份,荸荠56份,木棉根52份,栘枍50份,紫珠48份,花荵47份;制成所述西药成分的原料组成及重量份数为:胶体果胶铋1.3份,西咪替丁1.2份,枸橼酸铋钾1.1份。
所述药物由中药和西药成分组成,制成所述中药成分的原料组成及重量份数为:猴头菇70份,荷叶67份,鹿仙草65份,牛西西63份,胡荽60份,佩兰55份,仙人掌53份,南姜50份,荸荠49份,木棉根45份,栘枍43份,紫珠41份,花荵40份;制成所述西药成分的原料组成及重量份数为:胶体果胶铋0.9份,西咪替丁0.8份,枸橼酸铋钾0.7份。
所述药物由中药和西药成分组成,制成所述中药成分的原料组成及重量份数
为:猴头菇62份,荷叶58份,鹿仙草57份,牛西西56份,胡荽52份,佩兰47份,仙人掌44份,南姜43份,荸荠38份,木棉根37份,栘枍36份,紫珠33份,花荵32份;制成所述西药成分的原料组成及重量份数为:胶体果胶铋0.5份,西咪替丁0.4份,枸橼酸铋钾0.3份。
一种治疗急性胃粘膜病变的中西复方药物的制备方法,包括以下工艺步骤:
(1)将猴头菇、荷叶、牛西西、胡荽、南姜、荸荠和花荵放入容器中,加入相对混合物质量6~8倍量的蒸馏水浸泡2~3天后,加入3~4倍量的质量浓度为45%~55%的乙醇,加热回流4小时,过滤,得提取液;将过滤后获得的药渣再加入相对药渣质量4~6倍量的蒸馏水与1~2倍量的质量浓度为45%~55%的乙醇,加热回流2小时;过滤,得提取液;合并两次提取液,过滤,得滤液,浓缩至含水量为30%~40%的浸膏,备用;
(2)将鹿仙草和栘枍去除杂质,晒干,置于研钵内研末,得到过120目的细粉,备用;
(3)将佩兰去除杂质,洗净,稍润,切段晒干,置于研钵内研末,得到过160目的细粉,备用;
(4)将仙人掌去根去刺,削去外皮约3mm,切成条块状,置于锅内煎煮2小时,过滤,得滤液,浓缩至含水量为30%~40%的浸膏,备用;
(5)将木棉根和紫珠加入相对混合物质量6倍量的蒸馏水,煎煮3小时,过滤,得滤液,将滤液用文火浓缩至原滤液体积的20%,浓缩成70℃下相对密度为1.10~1.13的稠膏,备用;
(6)将胶体果胶铋、西咪替丁和枸橼酸铋钾置于研钵内研末,得到过220目的细粉,备用;
(7)将步骤(1)~步骤(6)所得的浸膏、细粉与细粉混合,浓缩成70℃下相对密度为1.10~1.13的稠膏,Co60照射灭菌,压成片剂,每片重量为30mg,即为所述的治疗急性胃粘膜病变的中西复方药物。
本发明所用中药的药效如下:
猴头菇:行气消食,健脾开胃,安神益智。用于食积不消,脘腹胀痛,脾虚食少,失眠多梦,食少便溏、胃及十二指肠溃疡、浅表性胃炎、神经衰弱、食道癌、胃癌、眩晕、阳痿等病症。现代医学研究证实,猴头菇具有独特的消化道系统保护、调理和修复功能,可助消化、益肝脾,解饥解渴、消除宿毒等多重功效。对食欲不振,恶心呕吐者,饮用该品后能迅速止呕,食欲可得到明显改善,对治疗肠癌有辅助作用,年老体弱者食用猴头菇,有滋补强身的作用。
荷叶:清热解暑,升发清阳,凉血止血。用于暑热烦渴,暑湿泄泻,脾虚泄泻,血热吐衄,水肿,食少腹胀,泻痢白带,脱肛,吐血衄血,咯血,便血崩漏。《随息居饮食谱》载:“凡上焦邪盛,治宜清降者,切不可用。”
鹿仙草:壮阳补肾,健脾理气,止血。用于阳痿,神经功能症,慢性肝炎,胃痛,消化道出血,月经过多。
牛西西:清热解毒,活血止血,通便杀虫。用于痢疾,肝炎,慢性肠炎,跌打损伤,内出血,血小板减少症,大便秘结,痈疮疥癣,脓泡疮。《陕西中草药》载:“活血散瘀,止血,清热解毒,润肠通便,治跌打损伤;内出血,紫癜症,汤火伤,腋庖疮,癣,阑尾炎,慢性肠炎,大便秘结。”现代医学研究证实,牛西西具有止血的作用。
胡荽:发表透疹,消食开胃,止痛解毒。用于风寒感冒,麻疹,痘疹透发不畅,含食积,脘腹胀痛,呕恶头痛,牙痛脱肛,丹毒,疮肿初起,蛇伤。《嘉佑本草》载:“消谷,治五脏,补不足,利大小肠,通小腹。”
佩兰:平肝潜阳,芳香化湿,醒脾开胃,发表解暑。用于湿浊中阻,脘痞呕恶,口中甜腻,口臭,多涎,暑湿表症,头胀胸闷。《现代实用中药》载:“为芳香性健胃、发汗、利尿药。用于冒寒性头痛,神经性头痛,传染性热病,腹痛,腰肾痛,结石等。
仙人掌:清热解毒,散瘀消肿,健胃止痛,镇咳。用于胃、十二指肠溃疡,急性痢疾,咳嗽,外用治流行性腮腺炎,乳腺炎,痈疖肿毒,蛇咬伤,烧烫伤。《陆川本草》载:“消炎解毒,排脓生肌,主治疮痈疖肿,咳嗽。”
南姜:温胃散寒,消食止痛。用于脘腹冷痛,胃寒呕吐,嗳气吞酸等。
荸荠:生津润肺,化痰利肠,通淋利尿,消痈解毒,凉血化湿,消食除胀。用于热病消渴,黄疸目赤,咽喉肿痛,小便赤热短少,外感风热,痞积等病症。现代医学研究证实,荸荠对金黄色葡萄球菌、大肠杆菌及绿脓杆菌均有一定的抑制作用,而且能够消热去痰,降低血压。
木棉根:清热利湿,收敛止血。用于慢性胃炎,胃溃疡,产后浮肿,赤痢瘰疬,跌打扭伤。《常用中草药手册》载:“清热利湿,治慢性胃炎,胃溃疡,产后浮肿。”
栘枍:清热解毒,收敛接骨。用于肠炎痢疾,烧烫伤,骨折,黄水疮,湿疹,子宫脱垂,风湿性关节炎,消化不良。
紫珠:止血,散瘀,消炎。用于衄血咯血,胃肠出血,子宫出血,上呼吸道感染,扁桃体炎,肺炎,支气管炎,外伤出血,烧伤。《中国药植图鉴》载:“对食道静脉出血,肠胃溃疡出血,鼻出血,创伤出血,肺出血以及拔牙出血均有良效。”现代医学研究证实,紫珠具有促进血液凝固的作用。
花荵:祛痰,止血,镇静。用于急、慢性支气管炎,胃溃疡出血,咳血,衄血,子宫出血,癫痫失眠,月经过多。《黑龙江常用中草药手册》载:“治急、慢性支气管炎,咳血吐血,衄血便血,子宫出血。”
本发明与现有技术相比,具有以下有益效果:
1、本发明药物采用中西医药结合的治疗方法比一般单纯的用中药、西药的治疗效果更佳,以收敛止血、消食开胃、止痛止呕、行气消食、健脾开胃为治疗原则,可以最大效率的提高中药成分与西药功效,发挥互补和提升作用,提高药用效果,且能够隔绝胃酸、酶及食物对溃疡粘膜的侵蚀作用应,对急性胃粘膜病变引发的上消化道出血、呕血、黑粪、上腹部不适等症状具有良好的治疗效果。
2、本发明药物针对性强,服用方便,吸收效果好,疗效显著,经临床验证,疗程短、治愈率高、标本兼治、成本低,是一种值得大量推广应用的药物。
具体实施方式
下面结合具体实施例对本发明做进一步阐述。
实施例1
本发明药物成分的原料组成及重量为:猴头菇83份,荷叶80份,鹿仙草78份,牛西西76份,胡荽73份,佩兰68份,仙人掌65份,南姜63份,荸荠61份,木棉根58份,栘枍56份,紫珠54份,花荵53份,胶体果胶铋1.7份,西咪替丁1.6份,枸橼酸铋钾1.5份。
本发明药物制备方法的工艺步骤为:
(1)将猴头菇、荷叶、牛西西、胡荽、南姜、荸荠和花荵放入容器中,加入相对混合物质量6~8倍量的蒸馏水浸泡2~3天后,加入3~4倍量的质量浓度为45%~55%的乙醇,加热回流4小时,过滤,得提取液;将过滤后获得的药渣再加入相对药渣质量4~6倍量的蒸馏水与1~2倍量的质量浓度为45%~55%的乙醇,加热回流2小时;过滤,得提取液;合并两次提取液,过滤,得滤液,浓缩至含水量为30%~40%的浸膏,备用;
(2)将鹿仙草和栘枍去除杂质,晒干,置于研钵内研末,得到过120目的细粉,备用;
(3)将佩兰去除杂质,洗净,稍润,切段晒干,置于研钵内研末,得到过160目的细粉,备用;
(4)将仙人掌去根去刺,削去外皮约3mm,切成条块状,置于锅内煎煮2小时,过滤,得滤液,浓缩至含水量为30%~40%的浸膏,备用;
(5)将木棉根和紫珠加入相对混合物质量6倍量的蒸馏水,煎煮3小时,过滤,得滤液,将滤液用文火浓缩至原滤液体积的20%,浓缩成70℃下相对密度为1.10~1.13的稠膏,备用;
(6)将胶体果胶铋、西咪替丁和枸橼酸铋钾置于研钵内研末,得到过220目的细粉,备用;
(7)将步骤(1)~步骤(6)所得的浸膏、细粉与细粉混合,浓缩成70℃下相对密度为1.10~1.13的稠膏,Co60照射灭菌,压成片剂,每片重量为30mg,
即为所述的治疗急性胃粘膜病变的中西复方药物。
用法用量:口服,每次2片,1片30mg,每日3次,早中晚各一次,饭后1小时温开水送服,20天为一个疗程,通常2~3个疗程痊愈,顽症需4~5个疗程痊愈,孕妇、哺乳期患者及对本品过敏者禁用。
实施例2
本发明药物成分的原料组成及重量为:猴头菇77份,荷叶74份,鹿仙草72份,牛西西70份,胡荽67份,佩兰62份,仙人掌60份,南姜58份,荸荠56份,木棉根52份,栘枍50份,紫珠48份,花荵47份,胶体果胶铋1.3份,西咪替丁1.2份,枸橼酸铋钾1.1份。
本实施例的药物制备方法工艺步骤及用法用量与实施例1相同。
实施例3
本发明药物成分的原料组成及重量为:猴头菇70份,荷叶67份,鹿仙草65份,牛西西63份,胡荽60份,佩兰55份,仙人掌53份,南姜50份,荸荠49份,木棉根45份,栘枍43份,紫珠41份,花荵40份;制成所述西药成分的原料组成及重量份数为:胶体果胶铋0.9份,西咪替丁0.8份,枸橼酸铋钾0.7份。
本实施例的药物制备方法工艺步骤及用法用量与实施例1相同。
实施例4
本发明药物成分的原料组成及重量为:猴头菇62份,荷叶58份,鹿仙草57份,牛西西56份,胡荽52份,佩兰47份,仙人掌44份,南姜43份,荸荠38份,木棉根37份,栘枍36份,紫珠33份,花荵32份,胶体果胶铋0.5份,西咪替丁0.4份,枸橼酸铋钾0.3份。
本实施例的药物制备方法工艺步骤及用法用量与实施例1相同。
毒性试验:
一、急性毒性试验:
1、试验步骤:随机选取健康小鼠50只,雌雄各半,体重14~23g,小鼠随
机分为两组,即实验组和对照组,实验前均禁食14小时后,分别按灌胃容积为5ml/kg的灌药量对实验组和对照组进行灌药,实验组选用本发明中西复方药物1片溶解在10ml的水中,对照组选取等量的生理盐水,实验组与对照组均一天灌药3次,灌药间隔时间为8小时,灌药后连续观察15天,并根据评价方法记录小鼠的毒性反应程度及死亡数。
2、评价方法:
3、结果:急性毒性试验小鼠灌药后腹部未见刺激反应,未出现死亡,呼吸正常,身体健康、体重未下降,对其进行相应解剖后,组织或内脏未见明显的异常改变。
二、长期毒性试验
1、试验步骤:随机选取健康大鼠50只,雌雄各半,体重198~218g,大鼠随机分为两组,即实验组和对照组,实验前均禁食14小时后,分别按灌胃容积为5ml/kg的灌药量对实验组和对照组进行灌药,实验组选用本发明中西复方药物1片溶解在40ml的水中,对照组选取等量的生理盐水,实验组与对照组第1~30天每天均灌药3次,灌药间隔时间为8小时,以后每5小时递增1.3倍剂量,灌药100天,根据急性毒性试验中的评价方法记录大鼠的的毒性反应程度及死亡数。
2、结果:长期毒性试验大鼠灌药后腹部未见刺激反应,未出现死亡,呼吸正常,对大小便、体重、脏器重量、肝肾功能、血脂等均无明显影响。
临床资料:
1、病例选择:
选择我院或外院确诊的急性胃粘膜病变患者480例临床观察,患者随机分成三组,治疗组、对照组A与对照组B,其各项范围如下:
三组病例的病程、症状轻重程度基本一致,无显著差异,具有可比性。
2、药物选择:
治疗组患者服用本发明药物,口服,每次2片,1片30mg,每日3次,早中晚各一次,饭后1小时温开水送服,20天为一个疗程,通常2~3个疗程痊愈,顽症需4~5个疗程痊愈,孕妇、哺乳期患者及对本品过敏者禁用。
对照组A服用复方维U颠茄铋铝片,口服,成人一次2~3片,一日3次。
对照组B服用曲昔匹特片,饭后口服,成人每次100mg(1片),一日3次。或遵医嘱。
3、疗效判定:
(1)治愈:上消化道出血、呕血、黑粪、上腹部不适、恶心、呕吐、反酸等状消失;身体恢复健康。
(2)有效:上述症状有所缓解。
(3)无效:上述症状无变化。
4、结果:
以上结果显示,治疗组治愈率和总有效率明显高于对照组A、对照组B。
典型病例举例:
1、王××,男,16岁,学生。患者因常服用某些西药导致患有急性胃粘膜病变,上消化道出血严重,面色苍白。服用本发明药物2个疗程后,以上症状消失,身体恢复健康,随访至今未复发。
2、张××,男,27岁,技术员。患者患有急性胃粘膜病变,曾服用过其它药物,效果不明显。经人推荐服用本发明药物2个疗程后,身体逐渐康复,继续服用1个疗程,身体痊愈,随访至今未复发。
3、范××,女,39岁,全职太太。患者患有急性胃粘膜病变,病变主要侵及胃粘膜层,发生充血,有糜烂、且累及十二指肠。服用本发明药物1个疗程后,症状好转,继续服用3个疗程,症状消失,身体痊愈,没有复发。
4、李××,男,48岁,项目经理。患者大量酗酒后引起急性胃粘膜糜烂、出血,恶心、吐血,被确诊为急性胃粘膜病变。曾服用过各种药物,效果均不佳。服用本发明药物3个疗程后,症状消失,没有复发。
5、杨××,女,56岁,退休教师。患者胃粘膜有损害,出现充血、水肿、糜烂、出血等症状,严重影响了日常的生活。服用本发明药物2个疗程后,症状好转,继续服用1个疗程,症状消失,身体恢复健康,随访至今未复发。
6、郑××,男,63岁,无业。患者因急性胃粘膜病变导致上消化道出血十分严重,会突然呕血、黑粪,伴有上腹部不适,恶心、呕吐及反酸等症状。服用本发明药物2个疗程后,症状明显减轻,继而服用1个疗程,身体恢复正常,随访至今未复发。
Claims (5)
1.一种治疗急性胃粘膜病变的中西复方药物,其特征在于:所述药物由中药和西药成分组成,制成所述中药成分的原料组成及重量份数为:猴头菇54~84份,荷叶51~81份,鹿仙草49~79份,牛西西47~77份,胡荽44~74份,佩兰39~69份,仙人掌36~66份,南姜34~64份,荸荠32~62份,木棉根29~59份,栘枍27~57份,紫珠25~55份,花荵24~54份;制成所述西药成分的原料组成及重量份数为:胶体果胶铋0.4~1.8份,西咪替丁0.3~1.7份,枸橼酸铋钾0.2~1.6份。
2.根据权利要求1所述的一种治疗急性胃粘膜病变的中西复方药物,其特征在于:所述药物由中药和西药成分组成,制成所述中药成分的原料组成及重量份数为:猴头菇77份,荷叶74份,鹿仙草72份,牛西西70份,胡荽67份,佩兰62份,仙人掌60份,南姜58份,荸荠56份,木棉根52份,栘枍50份,紫珠48份,花荵47份;制成所述西药成分的原料组成及重量份数为:胶体果胶铋1.3份,西咪替丁1.2份,枸橼酸铋钾1.1份。
3.根据权利要求1所述的一种治疗急性胃粘膜病变的中西复方药物,其特征在于:所述药物由中药和西药成分组成,制成所述中药成分的原料组成及重量份数为:猴头菇70份,荷叶67份,鹿仙草65份,牛西西63份,胡荽60份,佩兰55份,仙人掌53份,南姜50份,荸荠49份,木棉根45份,栘枍43份,紫珠41份,花荵40份;制成所述西药成分的原料组成及重量份数为:胶体果胶铋0.9份,西咪替丁0.8份,枸橼酸铋钾0.7份。
4.根据权利要求1所述的一种治疗急性胃粘膜病变的中西复方药物,其特征在于:所述药物由中药和西药成分组成,制成所述中药成分的原料组成及重量份数为:猴头菇62份,荷叶58份,鹿仙草57份,牛西西56份,胡荽52份,佩兰47份,仙人掌44份,南姜43份,荸荠38份,木棉根37份,栘枍36份,紫珠33份,花荵32份;制成所述西药成分的原料组成及重量份数为:胶体果胶
铋0.5份,西咪替丁0.4份,枸橼酸铋钾0.3份。
5.一种如权利要求1~4任一项所述的治疗急性胃粘膜病变的中西复方药物的制备方法,其特征在于:包括以下工艺步骤:
(1)将猴头菇、荷叶、牛西西、胡荽、南姜、荸荠和花荵放入容器中,加入相对混合物质量6~8倍量的蒸馏水浸泡2~3天后,加入3~4倍量的质量浓度为45%~55%的乙醇,加热回流4小时,过滤,得提取液;将过滤后获得的药渣再加入相对药渣质量4~6倍量的蒸馏水与1~2倍量的质量浓度为45%~55%的乙醇,加热回流2小时;过滤,得提取液;合并两次提取液,过滤,得滤液,浓缩至含水量为30%~40%的浸膏,备用;
(2)将鹿仙草和栘枍去除杂质,晒干,置于研钵内研末,得到过120目的细粉,备用;
(3)将佩兰去除杂质,洗净,稍润,切段晒干,置于研钵内研末,得到过160目的细粉,备用;
(4)将仙人掌去根去刺,削去外皮约3mm,切成条块状,置于锅内煎煮2小时,过滤,得滤液,浓缩至含水量为30%~40%的浸膏,备用;
(5)将木棉根和紫珠加入相对混合物质量6倍量的蒸馏水,煎煮3小时,过滤,得滤液,将滤液用文火浓缩至原滤液体积的20%,浓缩成70℃下相对密度为1.10~1.13的稠膏,备用;
(6)将胶体果胶铋、西咪替丁和枸橼酸铋钾置于研钵内研末,得到过220目的细粉,备用;
(7)将步骤(1)~步骤(6)所得的浸膏、细粉与细粉混合,浓缩成70℃下相对密度为1.10~1.13的稠膏,Co60照射灭菌,压成片剂,每片重量为30mg,即为所述的治疗急性胃粘膜病变的中西复方药物。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710029295.9A CN107913383A (zh) | 2017-01-16 | 2017-01-16 | 一种治疗急性胃粘膜病变的中西复方药物及制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710029295.9A CN107913383A (zh) | 2017-01-16 | 2017-01-16 | 一种治疗急性胃粘膜病变的中西复方药物及制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107913383A true CN107913383A (zh) | 2018-04-17 |
Family
ID=61898552
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710029295.9A Withdrawn CN107913383A (zh) | 2017-01-16 | 2017-01-16 | 一种治疗急性胃粘膜病变的中西复方药物及制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107913383A (zh) |
-
2017
- 2017-01-16 CN CN201710029295.9A patent/CN107913383A/zh not_active Withdrawn
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104225106B (zh) | 一种适用于人畜的无痕烫伤膏及其制备方法 | |
CN107349223A (zh) | 一种提高细胞活力的干细胞饮品及其制备方法 | |
CN103735745B (zh) | 一种治疗肺部肿瘤的中药制剂及制备方法 | |
CN107913383A (zh) | 一种治疗急性胃粘膜病变的中西复方药物及制备方法 | |
CN105031170A (zh) | 一种保健足浴粉及其制备方法 | |
CN103721156B (zh) | 一种治疗消化道出血的中药制剂及制备方法 | |
CN112641884B (zh) | 一种修复胃黏膜、提高胃动力的组合物及其制备方法 | |
CN107744549A (zh) | 一种治疗牙痛的药物及其制备方法 | |
CN107913402A (zh) | 一种治疗萎缩性胃炎的中西医结合药物及制备方法 | |
CN104825883A (zh) | 一种治疗鼻炎的中药方剂 | |
CN104258273A (zh) | 一种治疗胃溃疡的中药 | |
CN104223090B (zh) | 治疗糖尿病的药膳制剂及制法 | |
CN107913400A (zh) | 一种治疗急性腹膜炎的中西药组合物及制备方法 | |
CN107773671A (zh) | 一种用于治疗胃溃疡的药物及其制备方法 | |
CN106668709A (zh) | 回族中药花果胃癌消口服液及其制备方法 | |
CN108355025A (zh) | 一种治疗血栓性外痔的中药熏洗药剂及其制备方法 | |
CN106668227A (zh) | 回族中药参芪胃癌消口服液及其制备方法 | |
CN106668706A (zh) | 回族中药无花果胃癌消颗粒及其制备方法 | |
CN107362315A (zh) | 一种缓解放疗反应的中药组合物及其制备方法 | |
CN106668726A (zh) | 回族中药术风白血康片及其制备方法 | |
CN106668746A (zh) | 回族中药术风白血康颗粒及其制备方法 | |
CN106668531A (zh) | 回族中药六味血癌康丸及其制备方法 | |
CN106668225A (zh) | 回族中药参芪胃癌消片及其制备方法 | |
CN106668226A (zh) | 回族中药参芪胃癌消颗粒及其制备方法 | |
CN106668379A (zh) | 回族中药三七食管消癌口服液及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20180417 |
|
WW01 | Invention patent application withdrawn after publication |